Ionis Pharmaceuticals | IONS - Despesas Operacionais





Despesas Operacionais Alterar Data
Agios Pharmaceuticals USD 141.54M 11.8M 2025-12
Alnylam Pharmaceuticals USD 965.32M 84.27M 2025-12
Arrowhead Research USD 223.22M 10.86M 2025-12
Astellas Pharma JPY 436.66B 16.75B 2025-12
BioCryst Pharmaceuticals USD 146.17M 534.06M 2025-12
BioMarin Pharmaceutical USD 676.18M 131.65M 2025-12
Celltrion KRW 724.99B 6B 2025-09
Cspc Pharmaceutical CNY 5.4B 298.41M 2025-09
Deva Holding AS TRY 1.35B 178.26M 2023-09
Divis Laboratories Ltd INR 18.32B 1.08B 2025-12
Esperion Therapeutics USD 83.21M 14.06M 2025-12
Exelixis USD 362.75M 21.35M 2025-12
Halozyme Therapeutics USD 211.07M 74.73M 2025-12
Ionis Pharmaceuticals USD 418M 101.1M 2025-12
Kangmei Pharma CNY 1.39B 144.29M 2025-09
Knight Therapeutics CAD 118.61M 11.79M 2025-09
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 21.61M 11.59M 2025-12
Moderna USD 1.54B 259M 2025-12
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Neuren Pharmaceuticals AUD 25.23M 16.54M 2025-12
Neurocrine Biosciences USD 577.6M 22M 2025-12
Novartis USD 9.86B 115M 2025-09
Omeros USD 59.16M 20.13M 2024-06
OPKO Health USD 205.19M 11.6M 2025-09
Organigram Holdings CAD 108.11M 17.03M 2025-09
Ovoca Bio EUR 5.65M 3.45M 2022-06
Pfizer USD 12.91B 79.89B 2025-12
Pharma Mar EUR 46.87M 7.24M 2025-12
PTC Therapeutics USD 246.3M 38.78M 2025-12
Qiagen NV USD 418.54M 23.25M 2025-12
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sarepta Therapeutics USD 853.02M 390.78M 2025-12
Sartorius EUR 693.1M 29.4M 2025-09
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Tilray USD 237.52M 17.34M 2025-09
Ultragenyx Pharmaceutical USD 321M 9.82M 2025-12
Vertex Pharmaceuticals USD 1.93B 89.1M 2025-12
Zz Pientze Pharmaceu CNY 1.55B 129.66M 2025-09